Use of Janus kinase inhibitors in dermatomyositis: a systematic literature review.

Paik, Julie J; Lubin, Greg; Gromatzky, Austin; Mudd, Paul N; Ponda, Manish P; Christopher-Stine, Lisa

Paik, Julie J; Lubin, Greg; Gromatzky, Austin; Mudd, Paul N; Ponda, Manish P; Christopher-Stine, Lisa.

Affiliation

Paik JJ; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jpaik1@jhmi.edu.
Lubin G; Priovant Therapeutics, New York, NY, USA.
Gromatzky A; Priovant Therapeutics, New York, NY, USA.
Mudd PN; Priovant Therapeutics, New York, NY, USA.
Ponda MP; Priovant Therapeutics, New York, NY, USA.
Christopher-Stine L; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Clin Exp Rheumatol ; 41(2): 348-358, 2023 Mar.

Article in En | MEDLINE | ID: mdl-35766013

Subject(s)

Dermatomyositis; Janus Kinase Inhibitors; Lung Diseases, Interstitial; Muscular Diseases; Adult; Humans; Dermatomyositis/complications; Janus Kinase Inhibitors/therapeutic use; Immunoglobulins, Intravenous/therapeutic use; Muscle Weakness/complications; Lung Diseases, Interstitial/complications

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Lung Diseases, Interstitial / Dermatomyositis / Janus Kinase Inhibitors / Muscular Diseases Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Adult / Humans Language: En Journal: Clin Exp Rheumatol Year: 2023 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google